RaNA Therapeutics, a company that is using a novel approach to fight disease using RNA, is coming out of stealth today and announcing that Ronald Renaud Jr. will be the company's new chief executive officer. Read MoreHealthy deal
Cambridge drug developer Idenix Pharmaceuticals Inc. has filed lawsuits in Europe charging that biotechnology giant Gilead Sciences Inc. infringed on an Idenix patent when it marketed a popular new hepatitis C treatment in England, France, and Germany.
Get BetaBoston by Email
Make BetaBoston yours
Add tags to My Beta to follow the news stories, trends, and companies you care about.